Objective To investigate the clinical outcome of patients with acute-on-chronic liver failure (ACLF) and bacterial infection on admission after 72 hours of anti-infective therapy and related influencing factors.Methods An electronic database was used to select267 patients with ACLF and bacterial infection on admission who were admitted to the fifth Medical center of Chinese PLA General Hospital from January 2014 to March 2016, and their clinical features were analyzed.According to the outcome after 72 hours of anti-infective therapy, these patients were divided into effective group and ineffective group.The t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U rank sum test was used for comparison of non-normally distributed continuous data between two groups.The chi-square test was used for comparison of categorical data between two groups.A logistic regression analysis was used to identify the risk factors for outcome after 72 hours of anti-infective therapy and establish a predictive model, and the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of the new model.Results Hepatitis B virus infection observed in 161 patients and alcoholic liver disease observed in 60 patients were the most common causes, and 29 patients experienced septic shock.There were 312 case-times of bacterial infection, with ascites (199 patients) and the lung (77 patients) as the most common infection sites.A total of 49 strains were cultured, among which Escherichia coli (16 strains) and Klebsiella pneumoniae (13 strains) were the most common strains.A total of 20 patients also had fungal infection.Of all patients, 156 (58.4%) had response to anti-infective therapy.Compared with the ineffective group, the effective group had significantly lower incidence rates of acute kidney injury, hepatic encephalopathy, and septic shock, pulmonary infection rate, fungal infection rate, white blood cell count, neutrophil count, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, serum creatinine, international normalized ratio (INR) , and Model for EndStage Liver Disease (MELD) score (all P<0.05) and significantly higher ascites infection rate and prothrombin time activity (both P<0.05) .Compared with the ineffective group, the effective group had significantly lower 30-day mortality rate (15.2%vs 77.5%, χ2=97.942, P<0.001) and 90-day mortality rate (35.2%vs 91.7%, χ2=71.977, P<0.001) .The multivariate logistic regression analysis showed that baseline INR and the presence of septic shock were the risk factors for the outcome of anti-infective therapy.The new predictive model was logistic (p) =-5.907+2.260×septic shock (yes=1, no=0) +1.603×INR.At the cut-off value of-2.3, this model had an area under the ROC curve of 0.746, with a sensitivity of 62.2%, and a specificity of 78.2%.This new model had a higher diagnostic value than MELD score (Delong test, Z=2.402, P=0.016) .Conclusion INR and septic shock were independent influencing factors for predicting the therapeutic outcome of patients with ACLF and bacterial infection after 72 hours of anti-infective therapy.
[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Failure and Artificial Liver Group, Chinese Society Of Hepatology, Chinese Medical Association.Diagnostic and Treatment guidelines for liver failure (2012 version) [J].Chin J Infect Dis, 2013, 21 (3) :129-137. (in Chinese) 中华医学会感染病学会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝功能衰竭诊治指南 (2012年版) [J].中华传染病杂志, 2013, 31 (3) :129-137.
|
[2]FERNNDEZ J, ACEVEDO J, WIEST R, et al.Bacterial and fungal infections in acute-on-chronic liver failure:Prevalence, characteristics and impact on prognosis[J].Gut, 2018, 67 (10) :1870-1880.
|
[3]PALEVSKY PM, LIU KD, BROPHY PD, et al.KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J].Am J Kidney Dis, 2013, 61 (5) :649-672.
|
[4]Chinese Society of Hepatology, Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J].J Clin Hepatol, 2017, 33 (10) :1847-1863. (in Chinese) 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志, 2017, 33 (10) :1847-1863.
|
[5]Chinese Society of Gastroenterology and Chinese Society of Hepatology, Chinese Medical Association.Consensus on the diagnosis and treatment of hepatic encephalopathy in China (Chongqing, 2013) [J/CD].Chin J Front Med Sci:Electronic version, 2014, 6 (2) :81-93. (in Chinese) 中华医学会消化病学分会, 中华医学会肝病学分会.中国肝性脑病诊治共识意见 (2013年, 重庆) [J/CD].中国医学前沿杂志:电子版, 2014, 6 (2) :81-93.
|
[6]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Endoscopy, Chinese Medical Association.Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J].J Clin Hepatol, 2016, 32 (2) :203-219. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志, 2016, 32 (2) :203-219.
|
[7]Chinese Medical Association Critical Care Medicine Branch.Guidelines for the diagnosis and treatment of invasive fungal infections in critically ill patients (2007) [J].Chin J Intern Med, 2007, 46 (11) :960-966. (in Chinese) 中华医学会重症医学分会.重症患者侵袭性真菌感染诊断与治疗指南 (2007) [J].中华内科杂志, 2007, 46 (11) :960-966.
|
[8]HUANG X, DENG ZD, NI YX, et al.Chinese experts’consensus on prevention and control of multidrug resistance organism healthcare-associated infection[J].Chin J Infect Control, 2015, 14 (1) :1-9. (in Chinese) 黄勋, 邓子德, 倪语星, 等.多重耐药菌医院感染预防与控制中国专家共识[J].中国感染控制杂志, 2015, 14 (1) :1-9.
|
[9] Chinese Medical Association Critical Care Medicine Branch.Guidelines for the treatment of severe sepsis/septic shock in China (2014) [J].Chin Crit Care Med, 2015, 27 (6) :401-426. (in Chinese) 中华医学会重症医学分会.中国严重脓毒症/脓毒性休克治疗指南 (2014) [J].中华危重病急救医学, 2015, 27 (6) :401-426.
|
[10]Ministry Of Health of the People’s Republic of China.Diagnostic criteria for nosocomial infections (proposed) [J].Natl Med J China, 2001, 81 (5) :314-320. (in Chinese) 中华人民共和国卫生部.医院感染诊断标准 (试行) [J].中华医学杂志, 2001, 81 (5) :314-320.
|
[11]KAMATH PS, WIESNER RH, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology, 2001, 33 (2) :464-470.
|
[12] LI C, YOU SL, LIU HL, et al.The value of the baseline MELDscores, MELD-Na scores and i MELD scores in short-tern prognosis in hepatitis B virus related acute-on-chronic liver failure patients[J].Chin Crit Care Med, 2014, 26 (8) :539-543. (in Chinese) 李晨, 游绍莉, 刘鸿凌, 等.基线MELD、MELD-Na、i MELD 3种模型对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值[J].中华危重病急救医学, 2014, 26 (8) :539-543.
|
[13]MOREAU R, JALAN R, GINES P, et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology, 2013, 144 (7) :1426-1437.
|
[14]ZANG H, LIU HL, HAO YQ, et al.Risk factors for infections in patients with acute-on-chronic liver failure and their influences on short-term outcome[J].Infect Dis Info, 2015, 28 (5) :288-292. (in Chinese) 臧红, 刘鸿凌, 郝玉清, 等.慢加急性肝衰竭并发感染的危险因素及对近期预后的影响[J].传染病信息, 2015, 28 (5) :288-292.
|
[15]CAI J, ZHANG M, HAN T, et al.Characteristics of infection and its impact on short-term outcome in patients with acuteon-chronic liver failure[J].Medicine (Baltimore) , 2017, 96 (37) :e8057.
|
[16]WANG YJ.Liver failure related bacterial infection and antimicrobial treatment[J].J Prac Hepatol, 2014, 17 (2) :117-120. (in Chinese) 王英杰.肝衰竭并发细菌感染与抗生素治疗[J].实用肝脏病杂志, 2014, 17 (2) :117-120.
|
[17]MCKE MM, RUMYANTSEVA T, MCKE VT, et al.Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality[J].Liver Int, 2018, 38 (4) :645-653.
|
[18]LI C, WANG HF, WAN MB.Expression and dynamic changes of cytokine levels in patients with HBV-related acute-onchronic liver failure[J].Infect Dis Info, 2011, 24 (3) :151-155. (in Chinese) 李晨, 王慧芬, 万谟彬.HBV相关慢加急性肝衰竭患者体内细胞因子表达及动态变化的研究[J].传染病信息, 2011, 24 (3) :151-155.
|
[19]LI C, WANG HF, HU JH, et al.Expression and dynamic changes of Treg cells in peripheral blood and the levels of interleukin-6 in serum in HBV-related acute-on-chronic liver failure patients[J/CD].Chin J Clinicians:Electronic Edition, 2012, 6 (20) :6232-6237. (in Chinese) 李晨, 王慧芬, 胡瑾华, 等.乙型肝炎病毒相关慢加急性肝衰竭患者外周血调节性T细胞、血清白细胞介素-6表达及动态变化的研究[J/CD].中华临床医师杂志:电子版, 2012, 6 (20) :6232-6237.
|
[20]LI C, LIU HL, ZANG H, et al.Expression of myeloid-derived suppressor cells in peripheral blood in patients with HBV-related acute-on-chronic liver failure[J].Infect Dis Info, 2013, 26 (6) :343-347, 357. (in Chinese) 李晨, 刘鸿凌, 臧红, 等.外周血髓源性抑制细胞在HBV相关慢加急性肝衰竭患者中表达的研究[J].传染病信息, 2013, 26 (6) :343-347, 357.
|
[21]WASMUTH HE, KUNZ D, YAGMUR E, et al.Patients with acute on chronic liver failure display‘sepsis-like’immune paralysis[J].J Hepatol, 2005, 42 (2) :195-201.
|
[22]ZHAO Y, WANG YL, ZHAO KK, et al.Distribution and resistance of pathogens isolated from hepatic failure patients with septic shock[J].Prac J Med Pharm, 2013, 30 (3) :193-195. (in Chinese) 赵怡, 王永亮, 赵克开, 等.肝衰竭并感染性休克患者的病原菌谱及耐药性分析[J].实用医药杂志, 2013, 30 (3) :193-195.
|